Umary-USA.com is recalling approximately 3,046 bottles of UNAVY and UMOVY Acido Hialuronico (hyaluronic acid) supplements. Laboratory testing discovered that these products contain undeclared pharmaceutical drugs: dexamethasone, diclofenac, and omeprazole. These ingredients are not listed on the label and can cause serious health risks, especially when taken with other medications or by people with certain medical conditions. The products were sold in 30-count bottles containing 850mg caplets and were distributed nationwide across the United States via the internet.
The undeclared drugs pose significant health hazards. Dexamethasone is a corticosteroid that can cause serious side effects if stopped suddenly, diclofenac is an anti-inflammatory drug (NSAID) that may increase the risk of heart attack or stroke, and omeprazole is used to treat stomach acid but can interact poorly with other drugs. These undeclared ingredients can lead to severe allergic reactions or life-threatening drug interactions.
You have 2 options:
Undeclared ingredients: Dexamethasone, Diclofenac, and Omeprazole. Distributed by EREN NATURAL S.A. DE C.V.
Undeclared ingredients: Dexamethasone and Diclofenac. Distributed by EREN NATURAL S.A. DE C.V.
UNAVY ÁCIDO HALURONICO, 30 capsules in bottle, Front view
UNAVY ÁCIDO HALURONICO, 30 capsules in bottle, back view
UMOVY ÁCIDO HIALURÓNICO Lot Number 24215-C1
30 capsules in bottle (front view)
Product in bottle back view
Product in bottle back view
UMOVY ÁCIDO HIALURÓNICO Lot 25058
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.